Translational Neuroscience
27-28 October 2010
Ramada Frankfurt Messe
The treatment of neurological disorders has entered a new period of optimism. New insights into the underlying mechanisms of previously untreatable disorders, has led to a flurry of activity and a host of new drugs in development. However, the major bottleneck, and the biggest barrier to commercial exploitation, is clinical progression. More>> |